(Q43913169)

28 November 2017

title

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study (English)

1 reference

28 November 2017

1 reference

Raimund Margreiter

1

1 reference

28 November 2017

European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

359

1 reference

28 November 2017

issue

9308

1 reference

28 November 2017

page(s)

741-746

1 reference

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Early versus late acute renal allograft rejection: impact on chronic rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

The impact of an acute rejection episode on long-term renal allograft survival (t1/2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Hyperlipidemia in solid organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Hyperlipidaemia in renal transplantation—risk factor for long‐term graft outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

The effects of lipids on graft outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907875-3

7 January 2021

10.1016/S0140-6736(02)07875-3

Identifiers

DOI

1 reference

28 November 2017

1 reference